A case of paradoxical fibrosis and development of morphea in a patient on dupilumab

A case of paradoxical fibrosis and development of morphea in a patient on dupilumab

Bibliographic Details
Main Authors:	Bina Kassamali, BA, Scott A. Elman, MD, Anthony R. Sheets, MD, PhD, Avery H. LaChance, MD, MPH, Joseph F. Merola, MD, MMSc
Format:	Article
Language:	English
Published:	Elsevier 2021-11-01
Series:	JAAD Case Reports
Subjects:	dupilumab immunomodulator morphea paradoxical reaction sclerosing disorders
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512621005804

Similar Items

Development of keloidal morphea after treatment with cyclosporine in a case of recalcitrant generalized morphea
by: Sahar Dadkhahfar, et al.
Published: (2020-05-01)

The use of dupilumab for the treatment of recalcitrant brachioradial pruritus
by: Mary Kathryn Abel, AB, et al.
Published: (2021-04-01)

Disabling pansclerotic morphea
by: Nandy Mousumi, et al.
Published: (2005-01-01)

Epidermolysis bullosa pruriginosa responding to dupilumab
by: Rebecca C. Clawson, BS, et al.
Published: (2021-10-01)

Association Of Eosinophilic Fasciitis With Morphea
by: Zisova Lilia G., et al.
Published: (2014-09-01)

Zosteriform morphea: Wolf’s isotopic response in an immunocompetent patient
by: Ricardo Ruiz-Villaverde, et al.
Published: (2011-10-01)

Alopecia areata after dupilumab for atopic dermatitis
by: Krystal Mitchell, MBA, et al.
Published: (2018-03-01)

Morphea-like lesions after botulinum toxin A injections
by: Marina Landau, MD, et al.
Published: (2020-11-01)

The role of infection in morphea disease
by: Fatemeh Farhangdoost
Published: (2015-09-01)

Dupilumab in HIV-positive patients: A case series report of 4 patients
by: Ameen Alawadhi, MD, et al.
Published: (2020-12-01)

Morphea and vitiligo-A very uncommon association
by: Tasleem Arif, et al.
Published: (2015-04-01)

Segmental vitiligo with segmental morphea: An autoimmune link?
by: Pravesh Yadav, et al.
Published: (2014-01-01)

Superficial morphea: A rare condition and report of three unique cases
by: Kanthi Bommareddy, BSc, et al.
Published: (2021-04-01)

Improvement in a patient with hypereosinophilic syndrome after initiation of dupilumab treatment
by: Jill K. Wieser, MD, et al.
Published: (2020-04-01)

Dupilumab-Associated Blepharoconjunctivitis with Giant Papillae
by: Vingopoulos F, et al.
Published: (2020-07-01)

A case report of uveitis secondary to dupilumab treatment for atopic dermatitis
by: Marissa Ayasse, BS, et al.
Published: (2021-01-01)

Eczematous reactions to psoriasis biologics treated with dupilumab: A case series
by: Merav Koschitzky, BA, et al.
Published: (2021-05-01)

Successful treatment of Brunsting-Perry pemphigoid with dupilumab
by: Franklin R. Blum, BS, et al.
Published: (2021-04-01)

Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
by: Madeeha Mian, MD, et al.
Published: (2020-10-01)

Ophiasis treated with dupilumab
by: McKenna Abercrombie, DO, et al.
Published: (2021-10-01)

Atrophic type of morphea profundus – an Indian experience
by: Leena Raveendra, et al.
Published: (2013-04-01)

Generalized morphea/eosinophilic fasciitis overlap after epoxy exposure
by: Warren H. Chan, MS, et al.
Published: (2018-03-01)

Early morphea simulating patch-stage mycosis fungoides in two cases
by: Hamid R. Ghasemi Basir, et al.
Published: (2018-04-01)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
by: Amanda E. Zubek, MD, PhD, et al.
Published: (2021-01-01)

Ulcerative injection-site reaction associated with dupilumab therapy
by: Michael Phan, BS, et al.
Published: (2020-12-01)

Dupilumab: One therapy to treat multiple atopic diseases
by: Fatima Bawany, BA, et al.
Published: (2020-11-01)

Autoantibodies in Morphea: An Update
by: Sangita Khatri, et al.
Published: (2019-07-01)

Linear scleroderma and primary sclerosing cholangitis: An undescribed association
by: Iñigo Navarro Fernández, et al.
Published: (2020-01-01)

Pansclerotic morphea: A male child with hemiatrophy of lower limb
by: Malay K Dasgupta, et al.
Published: (2014-01-01)

The Value of Ultrasonography in the Diagnosis and Monitoring of Localized Morphea — Case Report
by: Chiriac Anca, et al.
Published: (2016-09-01)

Post-irradiation morphea in brest cancer: a case report
by: Jorge Llenas, et al.
Published: (2012-09-01)

Time to loss of response for dupilumab in ophiasis-pattern alopecia areata
by: Sarah Choe, BS, et al.
Published: (2021-09-01)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
by: Sean J. Igelman, BS, et al.
Published: (2020-02-01)

Treatment efficacy of dupilumab in a hyper-immunoglobulin E syndrome patient with severe atopic dermatitis
by: Chia-Jui Su, MD, et al.
Published: (2021-05-01)

Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report
by: Gefei Alex Zhu, MD, et al.
Published: (2020-04-01)

Full scalp hair regrowth in a 4-year-old girl with alopecia areata and atopic dermatitis treated with dupilumab
by: Diana Gruenstein, BA, et al.
Published: (2020-12-01)

Morphea and antithyroid antibodies
by: Aleksandra Dańczak-Pazdrowska, et al.
Published: (2018-07-01)

Morphea simulating paucibacillary leprosy clinically and histopathologically
by: José Saulo Torres Delgado, et al.
Published: (2013-01-01)

Laser Therapy for the Treatment of Morphea: A Systematic Review of Literature
by: Paulina Szczepanik-Kułak, et al.
Published: (2021-07-01)

Acceleration of cutaneous T-cell lymphoma following dupilumab administration
by: Kristen Russomanno, MD, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_1vkr0uttpsa850q8uvbhd1c2th